The novel 13 S ,14 S ‐epoxy‐maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A 4 hydrolase (LTA 4 H), and shifts macrophage phenotype
Open accessThe DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
Maresins are produced by macrophages from docosahexaenoic acid (DHA) and exert potent proresolving and tissue homeostatic actions. Maresin 1 (MaR1; 7 R ,14 S ‐dihydroxy‐docosa‐4 Z ,8 E ,10 E ,12 Z ,16 Z ,19 Z ‐hexaenoic acid) is the first identified maresin. Here, we investigate formation, stereochemistry, and precursor role of 13,14‐epoxy‐docosahexaenoic acid, an intermediate in MaR1 biosynthesis. The 14‐lipoxygenation of DHA by human macrophage 12‐lipoxygenase (hm12‐LOX) gave 14‐hydro(peroxy)‐docosahexaenoic acid (14‐HpDHA), as well as several dihydroxy‐docosahexaenoic acids, implicating an epoxide intermediate formation by this enzyme. Using a stereo‐controlled synthesis, enantiomerically pure 13 S ,14 S ‐epoxy‐docosa‐4 Z ,7 Z ,9 E ,11 E ,16 Z ,19 Z ‐hexaenoic acid (13 S ,14 S ‐epoxy‐DHA) was prepared, and its stereochemistry was confirmed by NMR spectroscopy. When this 13 S ,14 S ‐epoxide was incubated with human macrophages, it was converted to MaR1. The synthetic 13 S ,14 S ‐epoxide inhibited leukotriene B 4 (LTB 4 ) formation by human leukotriene A 4 hydrolase (LTA 4 H) ~40% ( P <0.05) to a similar extent as LTA4 (~50%, P <0.05) but was not converted to MaR1 by this enzyme. 1 3S ,14 S ‐epoxy‐DHA also reduced (~60%; P <0.05) arachidonic acid conversion by hm12‐LOX and promoted conversion of M1 macrophages to M2 phenotype, which produced more MaR1 from the epoxide than M1. Together, these findings establish the biosynthesis of the 13 S ,14 S ‐epoxide, its absolute stereochemistry, its precursor role in MaR1 biosynthesis, and its own intrinsic bioactivity. Given its actions and role in MaR1 biosynthesis, this epoxide is now termed 13,14‐epoxy‐maresin (13,14‐eMaR) and exhibits new mechanisms in resolution of inflammation in its ability to inhibit proinflammatory mediator production by LTA4 hydrolase and to block arachidonate conversion by human 12‐LOX rather than merely terminating phagocyte involvement.—Dalli, J., Zhu, M., Vlasenko, N. A., Deng, B., Haeggström, J. Z., Petasis, N. A., Serhan, C. N. The novel 13 S ,14 S ‐epoxy‐maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H) and shifts macrophage phenotype. FASEB J. 27, 2573–2583 (2013). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“At least some of these lipid metabolites are produced by macrophages (101) and also signal to macrophages to reduce inflammatory and fibrogenic gene expression (102).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [101]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resolvins and protectins in inflammation resolution
Serhan, C. N., & Petasis, N. A. (2011) · Chemical Reviews · doi:10.1021/cr100396c · Cited by 996
Self-citationMaresins: Novel macrophage mediators with potent antiinflammatory and proresolving actions
Serhan, C. N., Yang, R., Martinod, K., Kasuga, K., Pillai, P. S., Porter, T. F., Oh, S. F., & Spite, M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081880 · Cited by 908 · cited 10×
“In the biosynthesis of MaR1, DHA undergoes 14S-lipoxygenation to give 14-HpDHA that is converted to 13S,14S-epoxy-DHA, a proposed intermediate that is then further transformed to MaR1 (8).”
BackgroundMethodInfluentialSelf-citationResolvin D2 is a potent regulator of leukocytes and controls microbial sepsis
Spite, M., Norling, L. V., Summers, L., Yang, R., Cooper, D., Petasis, N. A., Flower, R. J., Perretti, M., & Serhan, C. N. (2009) · Nature · doi:10.1038/nature08541 · Cited by 695 · cited 1×
“The ability to identify resolvins revealed their remarkable protective actions, including their ability to enhance immune vigilance (23) and to stimulate host immune responses, lowering antibiotic requirements during infection (24).”
BackgroundSelf-citationInfection regulates pro-resolving mediators that lower antibiotic requirements
Chiang, N., Fredman, G., Bäckhed, F., Oh, S. F., Vickery, T., Schmidt, B. A., & Serhan, C. N. (2012) · Nature · doi:10.1038/nature11042 · Cited by 664
Self-citationMacrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain
Serhan, C. N., Dalli, J., Karamnov, S., Choi, A., Park, C., Xu, Z., Ji, R., Zhu, M., & Petasis, N. A. (2012) · The FASEB Journal · doi:10.1096/fj.11-201442 · Cited by 595 · cited 7×
“We next determined the identity of these DHA-derived products by assessing their respective MS-MS spectra and matching with synthetic and/or authentic standards (11).”
BackgroundInfluentialSelf-citationShimizu, T. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145616 · Cited by 576 · cited 1×
“3 min that corresponded to the known nonenzymatic hydrolysis products of LTA4 (3, 4) with the major peak at TR 5.”
Backgroundn–3 Fatty Acids in Cardiovascular Disease
De Caterina, R. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1008153 · Cited by 568
Dalli, J., & Serhan, C. N. (2012) · Blood · doi:10.1182/blood-2012-04-423525 · Cited by 547
Self-citationFatty acids and inflammation: The cutting edge between food and pharma
Calder, P. C. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.085 · Cited by 516 · cited 1×
“It is now well appreciated that -3 fatty acids exert a positive bearing on several important aspects of cardiovascular disease (30, 31).”
BackgroundMetabolic oxidation regulates embryonic stem cell differentiation
Yanes, O., Clark, J., Wong, D. M., Patti, G. J., Sánchez-Ruiz, A., Benton, H. P., Trauger, S. A., Desponts, C., Ding, S., & Siuzdak, G. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.364 · Cited by 506
Cited by
Items 201–283 of 283
Maresin1 ameliorates MSU crystal-induced inflammation by upregulating Prdx5 expression
Jiang, H., Song, D., Zhou, X., Chen, F., Yu, Q., Ren, L., Dai, Q., & Zeng, M. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00756-w · Cited by 12
“Recent studies have shown that during acute inflammation, MaR1 suppresses neutrophil infiltration, accelerates macrophage efferocytosis, and promotes tissue regeneration (Dalli et al 2013).”
BackgroundOxygenated lipid signaling in tumor-associated macrophages—focus on colon cancer
Colby, J. K., Jaoude, J. C., Liu, F., & Shureiqi, I. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9743-z · Cited by 13
Exploring the unique role of specialized pro-resolving mediators in cancer therapeutics
Quinlivan, K. M., Howard, I. V., Southan, F., Bayer, R. L., Torres, K. L., Serhan, C. N., & Panigrahy, D. (2024) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2024.106944 · Cited by 16
Self-citationThe First Total Synthesis of the Lipid Mediator PD2n-3 DPA
Tungen, J. E., Primdahl, K. G., & Hansen, T. V. (2020) · Journal of Natural Products · doi:10.1021/acs.jnatprod.0c00385 · Cited by 11
Maresin1: A multifunctional regulator in inflammatory bone diseases
Zhang, Z., Ji, C., Wang, M., Wang, M., She, X., Song, D., Xu, X., & Zhang, D. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110308 · Cited by 13
Yang, T., & Terrando, N. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-21735-8_4 · Cited by 13
Can polarization of macrophage metabolism enhance cardiac regeneration?
Lantz, C. W., Becker, A., & Thorp, E. B. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.07.003 · Cited by 10
Linking Lipid Metabolism and Immune Function: New Insights into Chronic Respiratory Diseases
Kotlyarov, S. N. (2025) · Pathophysiology · doi:10.3390/pathophysiology32020026 · Cited by 11
Maresin1 can be a potential therapeutic target for nerve injury
Wang, X., Botchway, B. O. A., Zhang, Y., Huang, M., & Liu, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114466 · Cited by 12
Pathak, Z., Jadav, T., Roy, A., Chopra, M., Singh, N., Sengupta, P., & Kumar, H. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2023.159395 · Cited by 11
Impact of Resolvin-E1 and Maresin-1 on Bone Marrow Stem Cell Osteogenesis under Inflammatory Stress
AlZahrani, S., Shinwari, Z., Alaiya, A. A., & Alkahtani, A. (2024) · Cells · doi:10.3390/cells13110932 · Cited by 10
“This modulation not only influences pain mechanisms but also supports tissue regeneration [34].”
BackgroundResolving inflammation in nonalcoholic steatohepatitis
Spite, M. R. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127583 · Cited by 9
“Of note, these results are consistent with prior studies showing that MaR1 regulates a proresolving macrophage phenotype (3).”
BackgroundResultLiu, B., Zhang, J., Zhang, K., Li, M., Jing, Y., Gu, S., Ding, H., Liang, Y., Zhou, H., & Dong, C. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.032588 · Cited by 8
Nshimiyimana, R., Libreros, S., Simard, M., Chiang, N., Rodríguez, A. R., Spur, B. W., Haeggström, J. Z., & Serhan, C. N. (2023) · American Journal of Hematology · doi:10.1002/ajh.26932 · Cited by 10
Self-citationBerrocal-Navarrete, F., Marín-Sanhueza, P., Norambuena-González, R., Martin, M. Q. S., Vielma, F. H., González, D. R., & Zúñiga‐Hernández, J. (2026) · Biomolecules · doi:10.3390/biom16010139 · Cited by 7
“This reaction leads to the formation of a Z/E configuration, ultimately yielding 7R,14S-dihydroxydocosa-4Z,8E,10E,12Z,16Z,19Z-hexaenoic acid, commonly known as maresin 1 [18,21] (Figure 2).”
InfluentialHydroperoxidation of Docosahexaenoic Acid by Human ALOX12 and pigALOX15-mini-LOX
Canyelles-Niño, M., González‐Lafont, À., & Lluch, J. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076064 · Cited by 7
“The stereochemistry of the bonds around C12 in 14S-H(p)DHA is critical for the formation of MaR1.”
BackgroundInfluentialBrown Adipose Tissue Activation in Humans Increases Plasma Levels of Lipid Mediators
Walker, M. E., Kodani, S. D., Mena, H. A., Tseng, Y.-H., Cypess, A. M., & Spite, M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae016 · Cited by 9
Szczuko, M., Zawadzka, K., Szczuko, U., Rudak, L., & Pobłocki, J. (2025) · Nutrients · doi:10.3390/nu17101715 · Cited by 9
“It is suggested that their synthesis only occurs during the resolution phase of inflammation [16].”
Omega-3 Polyunsaturated Fatty Acid Derived Lipid Mediators and their Application in Drug Discovery
Pazderka, C., Oliver, B. G. G., Murray, M. T., & Rawling, T. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180927100120 · Cited by 10
Enzymatic studies with 3-oxa n-3 DPA
Pangopoulos, M. K., Nolsøe, J. M. J., Antonsen, S. G., Colas, R. A., Dalli, J., Aursnes, M., Stenstrøm, Y., & Hansen, T. V. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103653 · Cited by 7
Self-citationPlatelet’s plea to Immunologists: Please do not forget me
Kumar, V., & Stewart, J. H. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113599 · Cited by 10
Evaluation of Cancer Cell Growth Suppressibility of ω-3 Fatty Acids and Their Metabolites
Tojo, T., Tsuruoka, M., Kondo, T., & Yuasa, M. (2022) · Journal of Oleo Science · doi:10.5650/jos.ess22183 · Cited by 6
Hansen, T. V., Dalli, J., & Serhan, C. N. (2016) · RSC Advances · doi:10.1039/c6ra00414h · Cited by 7
Self-citationLipidmediatoren und ihre Rolle bei Entzündungen und Allergien
Stockert, K. (2020) · Springer eBooks · doi:10.1007/978-3-662-58140-7_6 · Cited by 6
“Makrophagen generieren neben anderen SPMs auch 14S-Hydroxyperoxy-DHA (14S-HpDHA), das über 12-LOX in MaR1 umgewandelt wird (Dalli et al.”
BackgroundMaresin1 is a predictive marker of new digital ulcers in systemic sclerosis patients
Pellicano, C., Romaggioli, L., Miglionico, M., Colalillo, A., Ramaccini, C., Gigante, A., Muscaritoli, M., & Rosato, E. (2022) · Microvascular Research · doi:10.1016/j.mvr.2022.104366 · Cited by 5
Recent Advances in NMR Studies of Lipids
Pikuła, S., Bandorowicz‐Pikuła, J., & Groves, P. D. (2015) · Annual reports on NMR spectroscopy · doi:10.1016/bs.arnmr.2014.12.005 · Cited by 5
Maresin2 negatively regulates DC’s maturation via the MAPK/NF-κB pathway in DCs
Wang, C., Deng, J., Ding, Z., Zhu, H., Guo, Z., & Lu, J. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112785 · Cited by 4
Lipoxins, Resolvins, and the Resolution of Inflammation
Recchiuti, A., Cianci, E., Simiele, F., & Romano, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-27766-0_10 · Cited by 5
Oral omega-3 fatty acids promote resolution in chemical peritonitis
Chacon, A. C., Phillips, B. E., Chacon, M. A., Brunke-Reese, D., Kelleher, S. L., & Soybel, D. I. (2016) · Journal of Surgical Research · doi:10.1016/j.jss.2016.06.036 · Cited by 5
DAMP-Promoted Efferent Innate Immune Responses in Human Diseases: Inflammation
Land, W. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53868-2_5 · Cited by 4
Mu, X., & Xu, D. (2018) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.8b04203 · Cited by 4
Resolution of innate immune cells with proresolving lipid mediators in idiopathic pulmonary fibrosis
Ang, Y., Ng, A. J. K., Liao, W., Wong, K. Y. K., Wong, W. S. F., & Peh, H. Y. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf100 · Cited by 3
Biosynthesis and analytics of specialized pro-resolving mediators: facts and faults
Schebb, N. H., Kühn, H., Kampschulte, N., Flamand, N., Peters-Golden, M. L., Jakobsson, P., Claesson, H., Weylandt, K. H., Rohwer, N., Saul, M. J., et al. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101133 · Cited by 5
“MaR1 has an LTB 4 -related structure (7 R ,14 S - dihydroxy with an 8-trans ,10-trans ,12-cis conjugated triene), but it is not a product of LTA 4 hydrolase that forms LTB 4 (115).”
Liu, H., Chen, H., Han, T., Wang, X., Dai, J., Yang, X., Chan, S., Cannon, R. D., Yang, Y., Mousa, H., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40515 · Cited by 5
Fatty acid mediators and the inflammasome
Desmarais, F., Bergeron, K., Ntambi, J. M., Rassart, É., & Mounier, C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819404-1.00011-7 · Cited by 4
Macrophages and the Entrance of Resolution Phase Lipid Mediators
Serhan, C. N., Chiang, N., & Dalli, J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1311-4_13 · Cited by 3
Self-citationRodrigues, L. S., da Silva, J. A. R., Júnior, J. D. B. L., Silva, A. G. M. E., Rodrigues, T. C. G. D. C., da Silva, W. C., da Silva, T. C., de Castro, V. C. G., Alfaia, C. M., de Almeida, A. M., et al. (2023) · Animals · doi:10.3390/ani13243785 · Cited by 3
“…fatty acids of the omega-6 family, which have pro-inflammatory characteristics, can stimulate mutations that cause cancerous diseases, while omega-3 fatty acids have anti-inflammatory characteristics [65–67], which may reduce the appearance of malignant tumors, including breast cancer [68,69].”
BackgroundInflammatory Processes in the Dental Pulp
Cooper, P. R., & Smith, A. J. (2014) · Springer eBooks · doi:10.1007/978-3-642-55160-4_7 · Cited by 6
Biologically Active Lipids in Vascular Biology
Upchurch, C. M., & Leitinger, N. (2019) · Learning materials in biosciences · doi:10.1007/978-3-030-12270-6_9 · Cited by 3
Gonçalves, W. A., Melão, A. C. R., Teixeira, M. M., Rezende, B. M., & Pinho, V. (2018) · Springer eBooks · doi:10.1007/978-3-319-77658-3_6 · Cited by 3
Land, W. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53868-2_10 · Cited by 4
Herrera Vielma, F., Quiñones San Martin, M., Muñoz-Carrasco, N., Berrocal-Navarrete, F., Herrada, A. A., Olate-Briones, A., Zagmutt, S., Rodríguez-Rodríguez, R., González, D. R., & Zúñiga-Hernandez, J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1826739 · Cited by 2
Sousa, A. B., Martins, C., Sarmento, B. F. C. C., Barbosa, M. A., & Barbosa, J. N. (2025) · Biomaterials Advances · doi:10.1016/j.bioadv.2025.214238 · Cited by 2
Yavuzkır, Ş., Cinar, D. K., Çınar, A., Bildirici, F., & Aydın, S. (2025) · Diagnostics · doi:10.3390/diagnostics15192439 · Cited by 2
“Maresin-1 (MaR-1), Maresin-1 (MaR-1) is biosynthesized in macrophages through the 14-lipoxygenation of docosahexaenoic acid (DHA) followed by enzymatic conversion of 13S,14S-epoxy intermediates [27,28].”
Lu, X., Rehman, H., & Markworth, J. F. (2026) · Current topics in microbiology and immunology · doi:10.1007/82_2026_344 · Cited by 2
Maresin-1 and maresin-2 as synovial fluid biomarkers in psoriatic, rheumatoid, and osteoarthritis
Demir, S., Can, B., Esmez, Ö., Aydin, M. A., Gencer, S. Y., Bildirici, F., Koca, S. S., Sahin, İ., & Aydın, S. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1856412 · Cited by 2
“The positive correlation observed between MaR-1 and MaR-2 in our study suggests that maresins may be co-regulated within the synovial microenvironment through shared biosynthetic pathways or similar cellular sources (33, 41).”
Keeren, K., Huang, D., Smyl, C., Fischer, A., Rothe, M., & Weylandt, K. H. (2015) · Biology · doi:10.3390/biology4020314 · Cited by 3
“Maresins are synthesized from DHA by the 12-LOX enzyme [21,22].”
Enzymatic Oxidation of Polyunsaturated Fatty Acids
MURPHY, S. A., Al‐Aasswad, N. M. I., & Nicolaou, A. (2015) · Oxidative stress and disease · doi:10.1201/b18138-5 · Cited by 2
Cecconello, C., Claria-Ribas, P., & Norling, L. V. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822130-3.00018-1 · Cited by 3
Macrophage Proresolving Mediators-the When and Where
Dalli, J., & Serhan, C. N. (2017) · ASM Press eBooks · doi:10.1128/9781555819194.ch20 · Cited by 3
Self-citationStrategies for the Synthesis of Anti-inflammatory Metabolites of Unsaturated Fatty Acids
Kobayashi, Y., & Morita, M. (2019) · Springer eBooks · doi:10.1007/978-981-13-6244-6_9 · Cited by 3
Zahoor, I., Nematullah, M., Ahmed, M. E., Fatma, M., Sajad, M., Ayasolla, K., Cerghet, M., Palaniyandi, S. S., Ceci, V., Carrera, G., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.25.559216 · Cited by 2
“They are highly conserved resolution mediators with potent anti-inflammatory and proresolving properties and play a role in tissue regeneration in acute or chronic inflammatory-related disease models [18-20].”
Exploration of circulating metabolites in infants with abusive head trauma
Maret, E., Sajic, T., Wiskott, K., Gludic, S. L., Gilardi, F., Daali, Y., Fracasso, T., & Thomas, A. (2025) · Current Research in Neurobiology · doi:10.1016/j.crneur.2025.100154 · Cited by 1
“More specifically, 14(S)-HDHA is known to be part of the production of maresin-1, resulting in an anti-inflammatory and pro-resolving metabolite (Lu et al., 2010; Dalli and Serhan, 2016; Hong et al., 2014; Dalli et al., 2013).”
Burn Injury Triggers Distinct Transcriptomic Profiles in Adipose Tissue of Adult and Aged Mice
Bhattachan, P., Vlavcheski, F., Wojtowicz‐Piotrowski, S., & Jeschke, M. G. (2025) · The FASEB Journal · doi:10.1096/fj.202501420r · Cited by 1
“Interestingly, MaR1 and its precursors have been shown to promote a shift in macrophage phenotype toward an anti-inflammatory M2 profile [44].”
Docosahexaenoic acid supplementation inhibits monocyte exhaustion memory formation during sepsis
Caldwell, B. A., Wu, Y., Ie, S., Lucas, A., Conacher, B., Zhang, Y., Razani, B., & Li, L. (2026) · Inflammation Research · doi:10.1007/s00011-026-02194-w · Cited by 1
Beyond cartilage degeneration: osteoarthritis as a systems failure of inflammation regulation
Bar‐Or, D., Williams, Hausburg, M. A., Thomas, G. W., & Bar-Or, R. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1843245 · Cited by 1
“COX-2, 5-LOX, 12-LOX, and 15-LOX contribute to this switch by converting arachidonic acid and docosahexaenoic acid into mediators that first amplify and then resolve inflammation (70–72).”
Huang, L., Tu, M., Zhou, T., Chen, J. Y., Zhou, X., Tan, X., Li, Q., Li, Y., Mao, X., Long, Y., et al. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112756 · Cited by 1
Nakayama, S., Kanamori, A., Ikawa, T., Kamiya, K., Kudo, K., Yanagiya, R., Shimizu, T., Miki, Y., Nagasaki, Y., Araki, M., et al. (2026) · Science Advances · doi:10.1126/sciadv.adr9135 · Cited by 1
Enzymatic Oxidation of Polyunsaturated Fatty Acids
Nicolaou, A., Murphy, S., & Al-Aaswad, N. M. (2015) · CRC Press eBooks · doi:10.1201/b18138-8 · Cited by 1
Land, W. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53868-2_3 · Cited by 1
Cancer cell growth suppressibility of ω-3 fatty acid whose carboxy group converted to ester group
Tojo, T., Maeda, R., Kondo, T., & Yuasa, M. (2023) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2023.129191 · Cited by 1
Resolution of inflammation in Alzheimer’s disease
Wang, X. (2014) · Figshare
Acute Inflammation: A Protective Host Response that May Turn into Harm
Recchiuti, A. (2014)
Resolving neuroinflammation and pain with maresin 1, a specialized pro-resolving lipid mediator
Fattori, V., Ferraz, C. R., Rasquel-Oliveira, F. S., Zaninelli, T. H., Borghi, S. M., Casagrande, R., & Verri, W. A., Jr. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820237-1.00037-5
Biologically Active Lipids in Vascular Biology
Upchurch, C. M., & Leitinger, N. (2024) · Learning materials in biosciences · doi:10.1007/978-3-031-64591-4_9
Koç, M., Gökmuharremoğlu, Ö. Ö., & Çalışgan, N. C. (2025) · Biomedicines · doi:10.3390/biomedicines13122980
“Derived from omega-3 polyunsaturated fatty acids ( ω -3 PUFAs), mediators such as Resolvin D1 (RvD1) and Maresin 1 (MaR1) help terminate inflammation and restore tissue homeostasis [7,8].”
Jiang, H., Song, D., Zhou, X., Chen, F., Yu, Q., Ren, L., Dai, Q., & Zeng, M. (2023) · Figshare · doi:10.6084/m9.figshare.24630334
Wang, Y., Bao, Y., Liu, B., Li, H., Duan, H., Wang, Y., Zhang, J., Wu, W., Li, P., & Liu, X. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s556221 · Cited by 1
Jouvene, C. C. (2016) · theses.fr (ABES) · doi:10.70675/48490179zca84z4fb2z8a6dzbc32351d6d47 · Cited by 1
Chataigner, M. (2021) · theses.fr (ABES) · doi:10.70675/a4317690zc4c8z4ba6za738zd457c6bb9b74
Dynamics of macrophage polarization in zebrafish during the tissue injury and infection
Sipka, T. (2020) · theses.fr (ABES) · doi:10.70675/fe270cfcz6d95z4dfaz86a6z01efaf8a5ef7
García, C. C. (2023) · theses.fr (ABES) · doi:10.70675/6ea195a8zbbc3z4188z9a08zbe738e998182
Does exercise enhance maresin-1 production? A new direction in metabolic anti-inflammatory research
Alipour, M., Saeidi, A., ALNasser, M. N., Ayed, K., Almaqhawi, A., Hejazi, K., & Zouhal, H. (2026) · Exploration of Immunology · doi:10.37349/ei.2026.1003253
Chunyan, L., & Shen, J. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2026.104087 · Cited by 1
Gandhi, S., Shokravi, A., Buhrow, S., & Balas, M. (2026) · Biology · doi:10.3390/biology15141203
“…2 (MaR2), are DHA-derived mediators first identified in macrophage-associated resolution pathways; their biosynthesis is initiated by 12-LOX conversion of DHA to 14-hydroperoxy-DHA, followed by formation of a 13S,14S-epoxy-maresin intermediate that is enzymatically converted to MaR1 or MaR2 [9,10].”
Lotfi, R., Nasirifar, A., Rahmani, H., Falahi, S., & Kashiri, M. (2026) · Health Science Reports · doi:10.1002/hsr2.73012
Zhang, L., Hu, R., Qin, K., Wang, X., Wu, C., Liu, Z., Shao, X., Sun, J., Liu, Y., Xiao, S., et al. (2026) · Pain Research and Management · doi:10.1155/prm/1157250
Gilligan, M. M., & Panigrahy, D. (2026) · Current topics in microbiology and immunology · doi:10.1007/82_2026_356 · Cited by 1
Guler, M. A., Celik, M., Halıcı, H., Bayraktutan, Z., Yurdgülü, E. E., Ay, Y. A., & Keskin, H. (2026) · BMC Nephrology · doi:10.1186/s12882-026-05407-w
“Mares-ins, biosynthesized from omega-3 fatty acids, are among the most potent SPM families [16, 17].”
Serhan, C. N. (2026) · Current topics in microbiology and immunology · doi:10.1007/82_2026_354
Self-citationKotlyarov, S. (2026) · Studies in natural products chemistry · doi:10.1016/b978-0-443-51068-7.00014-3
Millar, B., Godson, C., & de Gaetano, M. (2026) · Current topics in microbiology and immunology · doi:10.1007/82_2026_367
Metadata
- Authors
- Dalli, J., Zhu, M., Vlasenko, N. A., Deng, B., Haeggström, J. Z., Petasis, N. A., & Serhan, C. N.
- Affiliations
- Brigham and Women's Hospital (US)
- University of Southern California (US)
- Karolinska Institutet (SE)
- Corresponding author
- Petasis, Nicos A.
- Serhan, Charles N.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2013-03-15
- Volume
- 27
- Issue
- 7
- Pages
- 2573-2583
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC3688739
- OpenAlex
- W2100994932
- Cited by
- 283
- References
- 32
- Citations by year
- 2026: 20 · 2025: 14 · 2024: 13 · 2023: 25 · 2022: 23 · 2021: 23 · 2020: 30 · 2019: 19 · 2018: 28 · 2017: 26 · 2016: 18 · 2015: 20 · 2014: 20 · 2013: 4
- FWCI
- 19.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (P01GM095467)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- maresin 1, epoxyeicosatrienoic acids, docosahexaenoic acid, 12-lipoxygenase, leukotriene A4 hydrolase, macrophage phenotype, leukotriene B4, specialized pro-resolving mediators, eicosanoid biosynthesis
- MeSH terms
- Arachidonate 12-Lipoxygenase, Cells, Cultured, Docosahexaenoic Acids, Epoxide Hydrolases, Humans, Leukotriene B4, Macrophages, Models, Chemical, Magnetic Resonance Spectroscopy, Molecular Structure, Arachidonic Acid, Biocatalysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.